MAM
AVNS

Martingale Asset Management’s Avanos Medical AVNS Stock Holding History

Martingale Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.53M Buy
180,360
+22,390
+14% +$302K 0.06% 291
2025
Q4 		$1.77M Buy
157,970
+21,154
+15% +$242K 0.05% 345
2025
Q3 		$1.58M Sell
136,816
-3,785
-3% -$44.3K 0.04% 382
2025
Q2 		$1.72M Buy
140,601
+16,718
+13% +$210K 0.04% 333
2025
Q1 		$1.78M Buy
123,883
+19,186
+18% +$300K 0.05% 326
2024
Q4 		$1.67M Buy
104,697
+5,868
+6% +$116K 0.04% 346
2024
Q3 		$2.37M Buy
98,829
+39,366
+66% +$900K 0.05% 269
2024
Q2 		$1.18M Sell
59,463
-5,599
-9% -$109K 0.03% 414
2024
Q1 		$1.3M Sell
65,062
-27,622
-30% -$534K 0.03% 407
2023
Q4 		$2.08M Buy
92,684
+1,464
+2% +$30.2K 0.04% 274
2023
Q3 		$1.84M Buy
91,220
+5,215
+6% +$118K 0.04% 284
2023
Q2 		$2.2M Sell
86,005
-3,348
-4% -$88.2K 0.04% 257
2023
Q1 		$2.66M Buy
89,353
+5,138
+6% +$149K 0.05% 215
2022
Q4 		$2.28M Buy
84,215
+48,848
+138% +$1.19M 0.04% 238
2022
Q3 		$771K Buy
35,367
+702
+2% +$18.3K 0.02% 509
2022
Q2 		$948K Buy
34,665
+1,405
+4% +$40.4K 0.02% 481
2022
Q1 		$1.11M Sell
33,260
-7,987
-19% -$257K 0.02% 452
2021
Q4 		$1.43M Sell
41,247
-18,450
-31% -$596K 0.02% 395
2021
Q3 		$1.86M Buy
59,697
+46,672
+358% +$1.58M 0.02% 330
2021
Q2 		$474K Buy
13,025
+3
+0% +$124 0.01% 603
2021
Q1 		$570K Buy
+13,022
New +$611K 0.01% 576
2018
Q3 		– Sell
-14,305
Closed -$819K – 952
2018
Q2 		$819K Sell
14,305
-48,308
-77% -$2.55M 0.01% 778
2018
Q1 		$2.89M Sell
62,613
-38,146
-38% -$1.81M 0.04% 435
2017
Q4 		$4.65M Sell
100,759
-91
-0.1% -$4.18K 0.06% 315
2017
Q3 		$4.54M Buy
100,850
+2,211
+2% +$94.3K 0.06% 339
2017
Q2 		$3.88M Buy
98,639
+27,304
+38% +$1.03M 0.05% 355
2017
Q1 		$2.72M Buy
71,335
+600
+0.8% +$23.4K 0.04% 455
2016
Q4 		$2.62M Buy
70,735
+5,397
+8% +$193K 0.04% 476
2016
Q3 		$2.27M Buy
65,338
+35,615
+120% +$1.25M 0.03% 477
2016
Q2 		$967K Buy
+29,723
New +$910K 0.02% 515

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Martingale Asset Management's AVNS Position: Q1 2026 in Review

Martingale Asset Management increased its Avanos Medical (AVNS) stake by 14% in Q1 2026, buying an estimated $302K and bringing the position to 180,360 shares worth $2.53M. The position accounts for 0.06% of the portfolio, ranked #291.

Martingale Asset Management first reported a position in AVNS in Q2 2016 and has held it in 30 quarters since. The position peaked at $4.65M in Q4 2017. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Martingale Asset Management held 180,360 shares of Avanos Medical worth $2.53M as of Q1 2026.
  • Martingale Asset Management bought 22,390 Avanos Medical shares in Q1 2026, an estimated $302K.
  • Avanos Medical made up 0.06% of Martingale Asset Management's portfolio in Q1 2026, its #291 holding.
  • Martingale Asset Management first reported a position in Avanos Medical in Q2 2016 and has held it in 30 quarters since.
  • Martingale Asset Management's Avanos Medical position peaked at $4.65M in Q4 2017.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Martingale Asset Management's 13F filing for Q1 2026, filed 13 May 2026.